SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.49 Cr | ₹4.33 Cr | ₹0.96 Cr | ₹1.67 Cr | ₹2.27 Cr |
What is the latest Contingent Liabilities ratio of SEQUENT SCIENTIFIC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.49 Cr |
| Mar2024 | ₹4.33 Cr |
| Mar2023 | ₹0.96 Cr |
| Mar2022 | ₹1.67 Cr |
| Mar2021 | ₹2.27 Cr |
How is Contingent Liabilities of SEQUENT SCIENTIFIC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.49 Cr | 3.79 | |
| Mar2024 | ₹4.33 Cr | 349.22 | |
| Mar2023 | ₹0.96 Cr | -42.20 | |
| Mar2022 | ₹1.67 Cr | -26.48 | |
| Mar2021 | ₹2.27 Cr | - | |
Compare Contingent Liabilities of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹9,607.4 Cr | 1.4% | 8.6% | 38.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | 1.4% |
8.6% |
38.2% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses